Details for 2023174717

Up to date per 24.05.2026

Actions

Title / Product Name

VERBESSERTE SYNTHESE EINES WICHTIGEN ZWISCHENPRODUKTES EINER KRAS-G12C-INHIBITORVERBINDUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2023174717

EP Publication Number

4234546

E-Number

1909891

Language

PCT Number

Publication Date

30.08.2023 A

15.04.2026 B1

Registration Date

15.04.2026

AT Publication Date

15.05.2026

Application Date

15.11.2019

Registration Number

Priorities

16.11.2018

201862768802 P

IPC

C07D 401/04 20060101AFI20231017BHEP

Maximum Duration of Protection

15.11.2039

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks CA 91320US

Representative

No representatives present

Inventor

PARSONS, Andrew Thomas Thousand Oaks, CaliforniaUS

COCHRAN, Brian McNeil Thousand Oaks, CaliforniaUS

POWAZINIK, IV, William Thousand Oaks, CaliforniaUS

CAPORINI, Marc Anthony Thousand Oaks, CaliforniaUS

Information about Fees